Summary:

• Group revenue dipped 1.6% year-on-year to S$9.78 million for the six months ended 30 November 2025, reflecting stable underlying medical services demand amid a softer case mix​

• Profit before tax climbed 17.4% to S$4.47 million and net profit rose 11.7% to S$4.05 million, boosted by a S$906,000 fair value gain on financial assets at FVTPL and higher share of profits from associates, partly offset by a S$429,000 fair value loss on derivatives and lower other income​

• Earnings attributable to shareholders increased 17.5% to S$3.97 million, driving basic EPS up to 2.59 cents from 2.20 cents a year ago​

• Net asset value per share improved to 15.07 cents from 13.66 cents as total equity expanded to S$22.8 million, with the balance sheet remaining ungeared and cash and bank balances rising to S$6.0 million​

• The Group paid a higher final dividend of 1.18 cents per share for FY2025 (vs 0.70 cents previously) during the half-year, underscoring confidence in cash generation even as operating expenses, notably staff costs and depreciation, continued to edge higher​